Cleared Traditional

STANBIO ALT/GPT (LUQUI-UV) TEST SET (K941314) - FDA 510(k) Clearance

Class I Chemistry device.

K941314 · Stanbio Laboratory · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1994
Decision
124d
Days
Class 1
Risk

K941314 is an FDA 510(k) clearance for the STANBIO ALT/GPT (LUQUI-UV) TEST SET. Classified as Nadh Oxidation/nad Reduction, Alt/sgpt (product code CKA), Class I - General Controls.

Submitted by Stanbio Laboratory (San Antonio, US). The FDA issued a Cleared decision on July 20, 1994 after a review of 124 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1030 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Stanbio Laboratory devices

Submission Details

510(k) Number K941314 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1994
Decision Date July 20, 1994
Days to Decision 124 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d slower than avg
Panel avg: 88d · This submission: 124d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CKA Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1030
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 126
Devices cleared under the same product code (CKA) and FDA review panel - the closest regulatory comparables to K941314.
DIMENSION VISTA ALBUMIN, ALKALINE PHOSPHATASE, ASPARTATE AMINO TRANSFERASE, CARBAMAZEPINE & ALANINE AMINO TRANSFERASE
K061020 · Dade Behring, Inc. · May 2006
ROCHE REAGENT FOR ALT
K924245 · Roche Diagnostic Systems, Inc. · Oct 1992
IL TEST ALT, PN 35311
K923623 · Instrumentation Laboratory CO · Sep 1992
PARAMAX ALANINE AMINOTRANSFERASE REAGENT
K901105 · Baxter Healthcare Corp · Mar 1990
COBAS READY STAT PROFILE REAGENT STRIP
K896234 · Roche Diagnostic Systems, Inc. · Feb 1990
ABBOTT ALT-ACTIVATED (LIQUID, LIST #01A55)
K890698 · Abbott Laboratories · Apr 1989